JP2014506230A5 - - Google Patents

Download PDF

Info

Publication number
JP2014506230A5
JP2014506230A5 JP2013528778A JP2013528778A JP2014506230A5 JP 2014506230 A5 JP2014506230 A5 JP 2014506230A5 JP 2013528778 A JP2013528778 A JP 2013528778A JP 2013528778 A JP2013528778 A JP 2013528778A JP 2014506230 A5 JP2014506230 A5 JP 2014506230A5
Authority
JP
Japan
Prior art keywords
compound
general formula
formula
range
gastric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013528778A
Other languages
English (en)
Japanese (ja)
Other versions
JP5868980B2 (ja
JP2014506230A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/002129 external-priority patent/WO2012035406A1/en
Publication of JP2014506230A publication Critical patent/JP2014506230A/ja
Publication of JP2014506230A5 publication Critical patent/JP2014506230A5/ja
Application granted granted Critical
Publication of JP5868980B2 publication Critical patent/JP5868980B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013528778A 2010-09-14 2011-09-14 トリプタミン誘導体、その製造方法および胃疾患についての使用 Expired - Fee Related JP5868980B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2173DE2010 2010-09-14
IN2173/DEL/2010 2010-09-14
PCT/IB2011/002129 WO2012035406A1 (en) 2010-09-14 2011-09-14 Tryptamine derivatives, their preparation and their use in gastropathy

Publications (3)

Publication Number Publication Date
JP2014506230A JP2014506230A (ja) 2014-03-13
JP2014506230A5 true JP2014506230A5 (enExample) 2014-05-22
JP5868980B2 JP5868980B2 (ja) 2016-02-24

Family

ID=44898070

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013528778A Expired - Fee Related JP5868980B2 (ja) 2010-09-14 2011-09-14 トリプタミン誘導体、その製造方法および胃疾患についての使用

Country Status (4)

Country Link
US (1) US8901317B2 (enExample)
EP (1) EP2616439B1 (enExample)
JP (1) JP5868980B2 (enExample)
WO (1) WO2012035406A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102439852B1 (ko) * 2015-04-17 2022-09-05 가천대학교 산학협력단 2-아미노퀴놀린-8-올 유도체, 및 이의 용도
US20190083462A1 (en) * 2016-03-18 2019-03-21 The Texas A&M University System Prevention of nsaid enteropathy with microbiota-derived tryptophan-metabolite
CA3176091C (en) 2020-12-31 2023-07-25 1280225 B.C. Ltd. Method of synthesizing indole compounds
CN113880749B (zh) * 2021-10-11 2023-06-30 江南大学 化合物JNc-463的制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345376A (en) * 1963-11-06 1967-10-03 Upjohn Co Polyhydro-6-methoxy-1-(3, 4, 5-trimethoxyphenyl)-9h-pyrido[3, 4-b]indoles
DE68925135T2 (de) * 1988-02-25 1996-08-01 I F L O S A S Di Giorgio E Ald Verfahren zur totalen Synthese von einer Indol-Struktur-Verbindungsklasse des Tryptamin-Typs, insbesondere Melatonin- oder N-Acetyl-5-methoxytryptamin mit hoher Reinheit und Löslichkeit, verwendbar in der AIDS-Therapie
CA2110574A1 (en) * 1991-06-21 1993-01-07 Lawrence I. Kruse Tryptamine analogues, their synthesis and their use as 5-ht1-like or 5-ht2 receptor agonists
US6403808B1 (en) * 1999-12-10 2002-06-11 Virginia Commonwealth University Selective 5-HT6 receptor ligands
JP4156825B2 (ja) * 2001-11-01 2008-09-24 株式会社ロッテ 抗鬱・抗ストレス剤及びそれを含有する組成物
CN1729174B (zh) * 2002-12-20 2015-10-21 西巴特殊化学品控股有限公司 胺的合成以及用于合成胺的中间体
JP3964417B2 (ja) * 2004-09-27 2007-08-22 国立大学法人金沢大学 インドール誘導体を有効成分とするα２受容体遮断剤及び血管拡張剤
JP5370957B2 (ja) * 2008-08-20 2013-12-18 学校法人日本大学 アポトーシス抑制剤

Similar Documents

Publication Publication Date Title
JP3775796B2 (ja) 抗炎症活性及び／又は鎮痛活性を有する硝酸エステル類及びそれらの製造方法
CN106573902B (zh) 氨基烷基苯并硫氮杂*衍生物及其用途
CN1243541C (zh) 2－(α－羟基戊基)苯甲酸盐及其制法和用途
JP6087284B2 (ja) Ｌ−オルニチンフェニルアセテートを製造するための方法
JP2010519260A5 (enExample)
RU2624446C9 (ru) Трициклические соединения, композиции, содержащие указанные соединения, и их применения
JP2016534063A5 (enExample)
CN102159541A (zh) 抗癌口服制剂
CN100344611C (zh) 4－硝基－2－[(4′－甲氧基)－苯氧基]－甲磺酰苯胺衍生物及其医药用途
JP5749410B2 (ja) ジヒドロピロロ［１，２−ｃ］イミダゾリルアルドステロンシンターゼまたはアロマターゼ阻害薬の新たな形態および塩
JP2013538849A5 (enExample)
WO2013150529A2 (en) Indole, indoline derivatives, compositions comprising them and uses thereof
CN105820104B (zh) 一种具有抗炎作用的吲哚-2-酰胺类化合物及其在制备抗炎药物中的应用
WO2015055114A1 (zh) 二苯乙烷衍生物及其应用
CN104557588B (zh) 咖啡酸和阿魏酸的同二聚体,其制备方法及其药物组合物
JP2011157375A5 (enExample)
CN1642926A (zh) 结晶帕瑞考昔钠
CN102579462A (zh) 甘草次酸衍生物制备抗炎药物中的应用
CN107162982B (zh) 一类具有抗癌活性的咪唑类化合物及其衍生物
CN116178384A (zh) 四种小檗碱中短链脂肪酸盐的制备
CN109096191B (zh) 氟比洛芬美普他酚酯药用化合物及其制备方法
CN107325052B (zh) 一类具有抗癌活性的咪唑酯类化合物及其衍生物
JP6872195B2 (ja) コラーゲン産生抑制剤
CN1212317C (zh) 新颖的酯或酰胺衍生物
WO2011085606A1 (zh) 用于抗感染的普卢利沙星的光学活性化合物和制备方法